Teva Receives First FDA Approval for Generic Pravachol(R); Appellate Court Denies Apotex Request for Injunctive Relief (RedNova)
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S.

FDA finds dozens new deficiencies at Andrx (Sun-Sentinel)
Food and Drug Administration inspectors have uncovered more than two dozen new manufacturing deficiencies at Andrx Corp.'s generic drug plant in Davie, according to an agency report released Monday.

Many FDA Experts Have Drug Industry Ties (Health Scout)
But votes on drug approvals wouldn't change much if they withdrew from advisory panels, study finds.